Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Nasal obstruction
ADR ID BADD_A02967
ADR Hierarchy
22      Respiratory, thoracic and mediastinal disorders
22.02      Respiratory disorders NEC
22.02.05      Upper respiratory tract signs and symptoms
22.02.05.037      Nasal obstruction
Description Any hindrance to the passage of air into and out of the nose. The obstruction may be unilateral or bilateral, and may involve any part of the NASAL CAVITY. [MeSH]
MedDRA Code 10028748
MeSH ID D015508
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Nasal obstruction | Nasal obstruction increased | Nasal Obstruction | Obstruction, Nasal | Obstructions, Nasal | Nasal Blockage | Blockage, Nasal | Blockages, Nasal | Nasal Blockages | Nasal Airway Obstruction | Airway Obstruction, Nasal | Obstruction, Nasal Airway | Unilateral Nasal Obstruction | Nasal Obstruction, Unilateral | Bilateral Nasal Obstruction | Nasal Obstruction, Bilateral | Obstruction, Bilateral Nasal
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00162Arginine--
BADD_D00410Celecoxib0.000574%
BADD_D00653Diclofenac0.000119%
BADD_D00981Gabapentin--
BADD_D01245Lansoprazole0.000419%
BADD_D01322Losartan0.000073%
BADD_D01507Mycophenolate mofetil0.001308%
BADD_D01617Ondansetron0.000100%
BADD_D01633Oxaliplatin0.001066%
BADD_D01933Ribavirin0.018131%
BADD_D01951Risperidone0.000804%
BADD_D02113Tamsulosin--
BADD_D02335Vardenafil0.001652%
BADD_D02392Zoledronic acid0.013122%
BADD_D02473Sodium chloride0.000604%
The 1th Page    1    Total 1 Pages